Incorporating cellular response to irradiation in personalized treatment planning to minimize radiation toxicity (RADPrecise)
Project information
MOX responsible
Paolo Zunino
Team
Francesca Ieva, Andrea Manzoni, Anna Paganoni
Start date
February 2019
End date
December 2022
Abstract
The RADprecise collaborative project aims to personalize radiotherapy treatment for cancer patients. We plan to improve the prediction of the risk for side effects after radiotherapy using multiple biomarkers from blood and tissue in addition to clinical and personal factors.